Column Group L P

Column Group L P is listed in filings as Director, 10% Owner at NGM Biopharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Apr 8, 2024, including purchase activity. Recent filings connect the profile to NGM Biopharmaceuticals, Inc. (NGM). The current snapshot covers public activity from Nov 17, 2023 to Apr 8, 2024. Reported amounts are shown as $3.6K to $11.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.